CCRL2 and polycystic ovary syndrome: We demonstrated that Ccrl2 mRNA expression markedly increased in the uterus of all experimental groups: VD3-treated, PCOS-induced, and PCOS-supplemented with VD3 (Figure 5C, p < 0.05).